血液系统恶性肿瘤危重成人患者的静脉血栓栓塞症:基于人群的队列研究
该研究为加拿大安大略省2006–2017年基于人群的队列研究,纳入76,803例新诊断血液系统恶性肿瘤的住院成人(平均年龄67岁,SD 15),其中20,524例至少一次入住ICU。主要结局VTE在ICU患者为3.7%,非ICU患者为1.2%(OR 3.08;95%CI 2.77-3.42);大出血分别为7.6%和2.4%(OR 3.33;95%CI 3.09-3.58)。校正潜在混杂因素后,危重病情与VTE的关联仍显著(OR 2.92;95%CI 2.62-3.25)。既往VTE史(OR 6.64;95%CI 5.42-8.14)与更高VTE发生率相关,诊断后超过1年才入院(OR 0.64;95%CI 0.56-0.74)和住院时血小板计数≤50×10⁹/L(OR 0.63;95%CI 0.48-0.84)与更低VTE发生率相关。
要点
- 血液系统恶性肿瘤住院患者中,ICU患者VTE发生率为3.7%,非ICU患者为1.2%,OR 3.08(95%CI 2.77-3.42)。
- 校正潜在混杂因素后,危重病情与VTE的关联仍显著,OR 2.92(95%CI 2.62-3.25)。
- ICU患者大出血发生率为7.6%,非ICU患者为2.4%,OR 3.33(95%CI 3.09-3.58)。
- 既往VTE史与更高VTE发生率相关,OR 6.64(95%CI 5.42-8.14)。
- 诊断后超过1年入院(OR 0.64;95%CI 0.56-0.74)和住院时血小板计数≤50×10⁹/L(OR 0.63;95%CI 0.48-0.84)与更低VTE发生率相关。
适用人群与场景
- 2006–2017年加拿大安大略省新诊断血液系统恶性肿瘤的住院成人,共76,803例,平均年龄67岁(SD 15)。
- 其中20,524例至少一次入住ICU,其余为非ICU住院患者。
研究设计与关键结果
- 研究类型:基于人群的队列研究;纳入2006–2017年加拿大安大略省新诊断血液系统恶性肿瘤的住院成人76,803例(平均年龄67岁,SD 15),其中20,524例至少一次入住ICU。
- 主要终点VTE(肺栓塞或深静脉血栓形成)发生率:ICU患者3.7% vs 非ICU患者1.2%,OR 3.08(95%CI 2.77-3.42)。
- 次要终点大出血发生率:ICU患者7.6% vs 非ICU患者2.4%,OR 3.33(95%CI 3.09-3.58);院内死亡率为次要终点,原文未报告其数值。
- 校正潜在混杂因素后,危重病情与VTE的关联仍显著:OR 2.92(95%CI 2.62-3.25)。
- 既往VTE史与更高VTE发生率相关:OR 6.64(95%CI 5.42-8.14)。
- 诊断后超过1年才入院与更低VTE发生率相关:OR 0.64(95%CI 0.56-0.74);住院时血小板计数≤50×10⁹/L与更低VTE发生率相关:OR 0.63(95%CI 0.48-0.84)。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在血液系统恶性肿瘤住院患者中,ICU患者VTE发生率(3.7%)和非ICU患者(1.2%)均需关注,危重病情与VTE风险升高相关(校正后OR 2.92;95%CI 2.62-3.25)。
- ICU患者大出血发生率(7.6%)高于非ICU患者(2.4%)(OR 3.33;95%CI 3.09-3.58),临床需同时评估血栓与出血风险。
- 既往有VTE史的患者VTE风险更高(OR 6.64;95%CI 5.42-8.14),住院时血小板计数≤50×10⁹/L者VTE发生率更低(OR 0.63;95%CI 0.48-0.84)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to describe the incidence of venous thromboembolism (VTE) and major bleeding among hospitalized patients with hematologic malignancy, assessing its association with critical illness and other baseline characteristics.
METHODS: We conducted a population-based cohort study of hospitalized adults with a new diagnosis of hematologic malignancy in Ontario, Canada, between 2006 and 2017. The primary outcome was VTE (pulmonary embolism or deep venous thrombosis). Secondary outcomes were major bleeding and in-hospital mortality. We compared the incidence of VTE between intensive care unit (ICU) and non-ICU patients and described the association of other baseline characteristics and VTE.
RESULTS: Among 76,803 eligible patients (mean age 67 years [standard deviation, SD, 15]), 20,524 had at least one ICU admission. The incidence of VTE was 3.7% in ICU patients compared to 1.2% in non-ICU patients (odds ratio [OR] 3.08; 95% confidence interval [CI] 2.77-3.42). The incidence of major bleeding was 7.6% and 2.4% (OR 3.33; 95% CI 3.09-3.58), respectively. The association of critical illness and VTE remained significant after adjusting for potential confounders (OR 2.92; 95% CI 2.62-3.25). We observed a higher incidence of VTE among specific subtypes of hematologic malignancy and patients with prior VTE (OR 6.64; 95% CI 5.42-8.14). Admission more than 1 year after diagnosis of hematologic malignancy (OR 0.64; 95% CI 0.56-0.74) and platelet count ≤ 50 × 109/L at the time of hospitalization (OR 0.63; 95% CI 0.48-0.84) were associated with a lower incidence of VTE.
CONCLUSION: Among patients with hematologic malignancy, critical illness and certain baseline characteristics were associated with a higher incidence of VTE.
参考来源
- Carini FC, Angriman F, Scales DC, et al. Venous thromboembolism in critically ill adult patients with hematologic malignancy: a population-based cohort study. Intensive Care Med. 2024. PMID: 38170226. doi:10.1007/s00134-023-07287-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。